Synthesis and characterization of 4‐aryl‐5‐(1‐aryl‐2‐methyl‐2‐nitropropyl)‐1,2,3‐selenadiazoles

The synthesis of a new set of selenadiazoles, 4‐aryl‐5‐(1‐aryl‐2‐methyl‐2‐nitropropyl)‐1,2,3‐selenadiazoles ( 4 ) derived from 2‐[4‐methyl‐4‐nitro‐1,3‐diarylpentylidene]‐1‐hydrazinecarboxamide ( 3 ) has been reported. THF has been found to be the solvent of choice for this reaction. Structural features of 3 and 4 have been analyzed by NMR and X‐ray techniques.     

A facile synthesis of pyrazolo[3,4‐D]pyridazines Via the 1,3‐dipolar cycloaddition of 3‐arylsydnones. Synthesis and computational studies of 1‐aryl‐4,5‐dihydro‐1H‐pyrazolo[3,4‐D]pyridazine‐3,6‐diones and their 3,6‐dichloro derivatives.

The synthetic utility of 1,3‐dipolar cycloaddition of DMAD to sydnones has been exploited in the preparation of new 1‐aryl‐4,5‐dihydro‐1H‐pyrazolo[3,4‐d]pyridazine‐3,6‐diones 7a‐j and their aromatic 3,6‐dichloro analogues 8a‐j . The lactam‐lactim tautomerism of compound 7a has been studied by the semi emperical (PM3) and ab initio methods.     

Synthesis of benzo[c][1,8]phenanthrolin‐6‐one through cyclization of N‐(isoquinol‐5‐yl)‐2‐bromo‐benzamide derivatives

In the course of our search for compounds with potential antitumor properties we have undertaken the synthesis of benzo[c][1,8]phenanthroline derivatives. Our project required the preparation of 8,9‐dimethoxy benzo[c][1,8]phenanthrolin‐6‐ones. This was first attempted by the lithiumdiisopropylamide cyclization of N‐(isoquinol‐5‐yl)‐2‐bromo‐4,5‐dimethoxybenzamide. The reaction led to 40% of the unexpected internal Diels‐Alder adduct 3,4‐dimethoxy‐6H‐pyrido[2,3‐i]6,8a‐ethenoindolo[cd]isoquinoline‐2(1H)‐one, which arose from a benzyne intermediate. In a second and more successful approach, the internal biaryl palladium diacetate‐assisted coupling reaction of properly N‐protected N‐(isoquinol‐5‐yl)‐2‐bromo‐4,5‐dimethoxybenzamide was studied. The optimisation of the protecting group necessary for this procedure led to a 64% yield of the target compound starting from N,N‐(isoquinol‐5‐yl)‐bis‐(2‐bromo‐4,5‐dimethoxybenzamide).     

Utility of 2‐[4‐(3‐oxobenzo[f]‐2H‐chromen‐2‐yl)‐1,3‐thiazol‐2‐yl]ethanenitrile in heterocyclic synthesis

Pyrazolo[4,3‐d]pyrimidines, pyrazolo[4,3‐d]triazolino[4,3‐a]pyrimidines, 3‐(2‐thiazolyl)thiophenes, thiazolo[3,2‐a]pyridine and pyrazolo[1,5‐a]pyrimidines were synthesized from 2‐[4‐(3‐oxobenzo[f]‐2H‐chromen‐2‐yl)‐1,3‐thiazol‐2‐yl]ethanenitrile. The newly synthesized compounds were elucidated by elemental analysis, spectral data, chemical transformation and alternative synthesis route whenever possible.     

Cyclocondensation reactions of heterocyclic carbonyl compounds XII. The double course of cyclization of 3‐(2‐aminobenzyl)‐1,2‐dihydro‐quinoxaline‐2‐one

The cyclocondensation reaction of compound 1 in boiling hydrochloric acid had an unexpected course. Instead of supposed 5,11‐dihydro‐quinoxalino[2,3‐b]quinoline 6a , 2‐(indol‐2‐yl)‐benzimidazole 4 was isolated as the major product.     

Reaction of 3‐aminoquinoline‐2,4‐diones with isocyanates. Synthesis of novel 3‐(3′‐alkyl/arylureido)quinoline‐2,4‐diones and their cyclic carbinolamide isomers

3‐Alkyl/aryl‐3‐amino‐1H,3H‐quinoline‐2,4‐diones react with alkyl/aryl isocyanates to give novel 3‐alkyl/aryl‐3‐ureido‐1H,3H‐quinoline‐2,4‐diones or 3a‐alkyl/aryl‐9b‐hydroxy‐3,3a,5,9b‐tetrahydro‐1H‐imidazo[4,5‐c]quinoline‐2,4‐diones. In some cases, a mixture of both products was obtained and separated by fractional crystallization. All compounds were characterized by their ¹H, ¹³C, ir and ms data and some of them also by ¹⁵N nmr data.     

Donor‐acceptor pyran‐2‐ones: Absorption and fluorescence spectra of 4‐substituted 2H‐1‐benzo/napthopyran‐2‐ones

The absorption spectra and emission spectra of 4‐substituted 2H‐1‐benzo/napthopyran‐2‐ones 3a‐1 have been determined in THF and DMSO. The substituent at the 4‐position of the 2H‐benzo/napthopyran‐2‐one, establishes a compact conjugation pathway in which the pyran‐2‐one nucleus can act as an acceptor ring.     

Synthesis of 9‐[1‐benzyl‐5‐(alkylsulfonyl)‐1H‐2‐imidazolyl]perhydro‐1,8‐acridinediones

Tricyclic dihydropyridines like ZM244085 are potential K_ATP channel openers. In this study 3‐cyanophenyl ring of ZM244085 was replaced with imidazolyl ring. So, 9‐[1‐benzyl‐5‐(alkylsulfonyl)‐1H‐2‐imidazolyl]perhydro‐1,8‐acridinediones ( 5d‐f ) were synthesized from 2‐alkylsulfonyl‐1‐benzyl‐5‐formylimidazole ( 4d‐f ) and cyclohexane‐1,3‐dione according to classical Hantzch synthesis as potential potassium channel modulators.     

One pot synthesis of diarylpyrido[3,2‐c]coumarins

Various diarylpyrido[3,2‐c]coumarins 3a‐l have been synthesized in one step by reacting 4‐hydroxy coumarins 1a‐d with α,β‐unsaturated ketones 2a‐c in the presence of ammonium acetate and acetic acid under Kroehnke's reaction conditions.     

Regioselective one pot synthesis of 2‐alkyl/aryl‐4h‐benzo[1,4] thiazine‐3‐one via microwave irradiation

A series of 2‐alkyl/aryl‐4H‐benzo[1,4]thiazine‐3‐ones have been synthesized by microwave irradiation of ethyl‐2‐bromo‐2‐alkyl/aryl acetate and 2‐amino thiophenol in the presence of 1,8‐diazabicyclo‐[5.4.0] undec‐7‐ene and N‐methylpiperidine. All compounds were characterized by ¹H NMR, ¹³C NMR and elemental analyses, and by X‐ray crystallography in the case of 2‐methyl‐4H‐benzo[1,4]thiazin‐3‐one.     

Isothiazolo[5,4‐d]isoxazole S,S‐dioxides and pyrazolo [3,4‐d]‐isothiazole S,S‐dioxides through cycloaddition reaction on 3‐benzylaminoisothiazole S,S‐dioxides

By reacting 4,5‐unsubstituted isothiazole dioxides with diazoalkanes and nitrile oxides bicyclic pyrazolo[3,4‐d]isothiazole and isothiazolo[5,4‐d]isoxazole S,S‐dioxides were obtained in good yield through a regioselective cycloaddition reaction. Through cycloaddition reaction of 3‐benzylamino‐4‐bromo‐isothiazole S,S‐dioxide labile cycloadducts were formed that underwent in situ dehydrobromination affording the corresponding aromatized compounds.     

An efficient synthesis of benzo[b][1,8]naphthyridine‐3‐carboxylic methyl esters

Methyl‐3‐(2‐chloroquinolin‐3‐yl)acrylates 5a‐i on reaction with methyl amine in acetonitrile yielded methyl‐3‐[2‐(methylamino)quinolin‐3‐yl]acrylates 6a‐i . When, these were followed by the reaction with the Vilsmeier reagent, they afforded methyl benzo[b][1,8]naphthyridin‐3‐carboxylate 7a‐i in good yields.     

Synthesis,structure and biological activities of [α‐(alkylcarbonyl)‐2‐(1,2,4‐triazol‐1‐yl)]ethyl‐N,N‐dialkydithiocarbamate derivatives

Seven 1,2,4‐triazole compounds containing the N,N‐dialkyldithiocarbamate group were designed and synthesized. Their structures were identified using infrared spectroscopy, element analysis, ¹H NMR spectroscopy and mass spectrometry, and in two cases by single crystal X‐ray diffraction. The result of the biological test showed that the seven compounds all have fungicidal and plant growth‐regulating activities.     

Synthesis and pharmacological investigation of novel 4‐(4‐Ethyl phenyl)‐1‐substituted‐4H‐[1,2,4]triazolo[4,3‐a]‐quinazolin‐5‐ones as new class of H1‐antihistaminic agents

A series of novel 4‐(4‐ethylphenyl)‐1‐substituted‐4H‐[1,2,4]triazolo[4,3‐a]quinazolin‐5‐ones were synthesized by the cyclization of 2‐hydrazino intermediate with various electrophile. The starting material 2‐hydrazino compound was synthesized from 2‐ethyl aniline by a new innovative route with improved yield. When tested for their in vivo H₁‐antihistaminic activity on conscious guinea pigs, all the test compounds significantly protected the animals from histamine induced bronchospasm. The compound II emerged as the most active compound of the series and it is more potent (73.93% protection) when compared to the reference standard, chlorpheniramine maleate (71% protection), it showed negligible sedation (10%) when compared to chlorpheniramine maleate (30%). Therefore compound II will serve as prototype molecule for further development as a new class of H₁‐antihistamines     

Synthetic approaches to bridgehead nitrogen methanesulfonamide derivatives of 3‐amino‐2‐thioxo‐2,3‐dihydrothieno[2,3‐d]pyrimidin‐4(1H)‐ones,potential cox‐2 selective inhibitors

Methane sulfonamide derivatives of 3‐amino‐2‐thioxo‐2,3‐dihydrothieno[2,3‐d]pyimidin‐4(1H)‐one, potential selective COX‐2 inhibitors, were synthesized and their structural elucidation is here reported. Some derivatives, at 10 μM concentration, showed a significant percentage of inhibition in some in vitro experiments.     

Synthesis and antimicrobial activity of 2‐(acyl or carboxyalkyl)‐3‐(H or alkyl or aryl)‐5 (or ‐6 or ‐8)‐monochloro, 7‐fluoro‐substituted‐4H‐1,4‐benzothiazines

A series of 2‐(acyl or carboxyalkyl)‐3‐(H or alkyl or aryl)‐5 (or ‐6 or ‐8)‐monochloro, 7‐fluoro‐substituted‐4H‐1,4‐benzothiazines 3a‐x were prepared to investigate their potential biological activity. In this work the 3a‐w structures are supported with physical and analytical data and the results of their in vitro antimicrobial activity against some strains Gram positive, Gram negative, and Fungi are reported. It was found that compounds 3a, 3d displayed interesting antibacterial activity, whereas compound 3f displayed interesting antifungal activity.     

Synthesis of some new 4‐substituted‐3, 5‐bis(2‐pyridyl)‐1h‐pyrazole

Several 4‐substituted‐3, 5‐bis(2‐pyridyl)‐1H‐pyrazoles, where the substituent is chloro, bromo, iodo, nitro, diazo, were synthesized under mild reaction conditions in high yields. The structures of the products were characterized by ¹H NMR, ¹³C NMR, ESI‐MS, IR and elemental analyses.     

Synthesis and tautomerization of 6,7‐dihydro‐(1,2,3)‐triazolo[1,5‐a]pyrimidines

The condensation of 5‐amino‐4‐phenyl‐1,2,3‐triazole ( 1 ) with chalcones 2a‐e or 3‐dimethylamino‐propiophenone ( 4f ) leads to the 6,7‐dihydro‐(1,2,3)‐triazolo[1,5‐a]pyrimidines 3a‐f. The equilibrium of 3 and the tautomeric 4,7‐dihydro‐(1,2,3)‐triazolo[1,5‐a]pyrimidines 3′ is described.     

Reactivity of 3‐amino‐3H‐quinazolin‐4‐one derivatives towards some electrophilic and nucleophilic reagents and using of the products in the building of some interesting heterocycles as anticancer agent

The chemical reactivity of N‐[1‐(3‐amino‐6,8‐dibromo‐4‐oxo‐3,4‐dihydro‐quinazolin‐2‐yl)‐2‐(2‐chlorophenyl)‐vinyl]benzamide ( 3 ) towards electrophilic and nucleophilic reagents have been reported. Structures of the products 3‐24 have been confirmed by elemental analysis and spectral data (IR, ¹H‐NMR, ¹³C and MS). The bioassay indicates that some of the prepared compounds have a good selective anticancer activity.